| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/25/2010 | WO2009149179A3 Enhanced antiviral therapy methods and devices |
| 02/25/2010 | WO2009140236A3 Staphylococcus aureus-specific antibody preparations |
| 02/25/2010 | WO2009138494A3 Amino acid sequences directed against toll-like receptors and their use for the treatment of diseases related to toll-like receptors |
| 02/25/2010 | WO2009137632A3 Hiv immunogen and method of making and using same |
| 02/25/2010 | WO2009133379A8 Dihydroorotate dehydrogenase as antifungal drug target and quinazolinone-based inhibitors thereof |
| 02/25/2010 | WO2009128952A3 Compositions of toll-like receptor agonists and papillomavirus antigens and uses thereof |
| 02/25/2010 | WO2009126308A3 Compositions and methods for vaccine and virus production |
| 02/25/2010 | WO2009101216A3 Omega-cyclohexylalkan-1-oles and use thereof as antimicrobial actives to combat body odor |
| 02/25/2010 | WO2009089822A3 Use of an acetylsalicylic acid salt for the treatment of viral infections |
| 02/25/2010 | WO2009077471A3 Azolylmethyloxiranes, use thereof and agents containing the same |
| 02/25/2010 | WO2009077443A3 Azolylmethyloxiranes, use thereof and agents containing the same |
| 02/25/2010 | WO2008156349A3 Formulations that contain combination of zink sulphate and eteric oil of achilea millefolium for treatment of the herpes simplex virus |
| 02/25/2010 | WO2008144347A8 Combinations comprising a fluoroquinolone for treating, reducing, ameliorating, or preventing infections |
| 02/25/2010 | US20100048698 Macrocyclic diterpenes for treating conditions associated with protein kinase c |
| 02/25/2010 | US20100048672 Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications |
| 02/25/2010 | US20100048659 Aqueous compositions containing metronidazole |
| 02/25/2010 | US20100048634 Method for treating apathy syndrome |
| 02/25/2010 | US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/25/2010 | US20100048585 Quinoline derivatives as antibacterial agents |
| 02/25/2010 | US20100048583 Novel Heterocyclic NF-kB Inhibitors |
| 02/25/2010 | US20100048575 Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 02/25/2010 | US20100048565 Benzimidazole derivatives |
| 02/25/2010 | US20100048563 Substituted indolepyridinium as anti-infective compounds |
| 02/25/2010 | US20100048559 PYRIDO(3,2-d)PYRIDMIDINES USEFUL FOR TREATING VIRAL INFECTIONS |
| 02/25/2010 | US20100048558 Thienopyridines |
| 02/25/2010 | US20100048557 Triazolopyridine JAK Inhibitor Compounds and Methods |
| 02/25/2010 | US20100048544 Pyrrolo (3, 2, 1-ij) quinoline-4-one-derivatives for treating tuberculosis |
| 02/25/2010 | US20100048528 Heterocyclic compounds as inhibitors of beta-lactamases |
| 02/25/2010 | US20100048504 Crystalline and amorphous forms of beta-l-deoxythymidine |
| 02/25/2010 | US20100048500 Anti-viral nucleoside analogs and methods for treating viral infections, especially HIV infections |
| 02/25/2010 | US20100048498 Stable non-dihydrate azithromycin oral suspensions |
| 02/25/2010 | US20100048495 Core 2 GlcNAc-T inhibitors III |
| 02/25/2010 | US20100048493 Method of administering oral flora-improving agent, antibacterial agent and growth promoter |
| 02/25/2010 | US20100048470 Immunotoxins for the treatment of diseases related to cmv infection |
| 02/25/2010 | US20100048469 Antimicrobial peptides |
| 02/25/2010 | US20100048465 Peptide mimics of melanocyte stimulating hormone |
| 02/25/2010 | US20100048463 Template-fixed peptidomimetics |
| 02/25/2010 | US20100048457 Glycoprotein for treating chronic obstructive pulmonary diseases |
| 02/25/2010 | US20100047373 Method for Extracting Plants of the Genus Pelargonium, Extract Produced According to Said Method, and Use Thereof |
| 02/25/2010 | US20100047366 Articles with antibacterial and antifungal activity |
| 02/25/2010 | US20100047362 Method and Pharmaceutical Composition for Improvement of Wound Healing |
| 02/25/2010 | US20100047321 Silver antimicrobial composition and use |
| 02/25/2010 | US20100047286 Recombinant BCG strains with enhanced ability to escape the endosome |
| 02/25/2010 | US20100047283 Francisella strain for live vaccine |
| 02/25/2010 | US20100047280 Flavivirus ns1 subunit vaccine |
| 02/25/2010 | US20100047277 Virosomes, methods of preparation, and immunogenic compositions |
| 02/25/2010 | US20100047274 Inoculation of recombinant viral vectors for rapid pre-exposure prevention and post-exposure protection against alpha-virus-induced encephalitides |
| 02/25/2010 | US20100047273 Coxsackie B virus and type 1 diabetes |
| 02/25/2010 | US20100047272 Therapeutic vaccine comprising mycobacterial heat shock protein 70 |
| 02/25/2010 | US20100047271 Vaccine compositions |
| 02/25/2010 | US20100047268 Fusion proteins of hiv regulatory/accessory proteins |
| 02/25/2010 | US20100047267 Staphylococcus aureus proteins and nucleic acids |
| 02/25/2010 | US20100047261 Base-modified rna for increasing the expression of a protein |
| 02/25/2010 | US20100047252 Antibody with protein a selectivity |
| 02/25/2010 | US20100047250 Activation epitope of fcy rii (cd32), binding molecules that specifically bind the epitope and means and methods for the detection of the epitope, and uses of said epitope or said binding molecules |
| 02/25/2010 | US20100047231 Immuno-Stimulant Combination for Prophylaxis and Treatment of Hepatitis C |
| 02/25/2010 | US20100047224 Biosilica-Adhesive Protein Nanocomposite Materials: Synthesis and Application in Dentistry |
| 02/25/2010 | US20100047220 Substances |
| 02/25/2010 | DE102008039254A1 Medicament, useful e.g. for treating infectious- and purulent inflammatory diseases of e.g. eyes, comprises benzyl-dimethyl-(3-(myristoylamino)-propyl)-ammonium chloride, dimethyl-(3-(myristoylamino)-propyl)-amine oxide and solvent |
| 02/25/2010 | DE102008038222A1 Indazol-5-carbonsäurehydrazid-derivate Indazole-5-carboxylic acid derivatives |
| 02/25/2010 | DE102008038221A1 7-Azaindolderivate 7-azaindole derivatives |
| 02/25/2010 | DE102008038220A1 Oxadiazolderivate Oxadiazole |
| 02/25/2010 | CA2735130A1 Compounds and methods for treating respiratory diseases |
| 02/25/2010 | CA2734734A1 Siderophore-mediated iron uptake in bacterial infection |
| 02/25/2010 | CA2734643A1 Avian influenza virus antigen, and booster immunization method for avian influenza vaccine in combination with mucosal adjuvant which is effective through oral administration |
| 02/25/2010 | CA2734578A1 Antibodies to ccr2 |
| 02/25/2010 | CA2734489A1 Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 02/25/2010 | CA2734486A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 02/24/2010 | EP2157085A1 Oxazole, derivatives of tetracyclines |
| 02/24/2010 | EP2156845A1 Combined vaccines comprising hepatitis B surface antigen and other antigens |
| 02/24/2010 | EP2155783A2 Cross-species-specific cd3-epsilon binding domain |
| 02/24/2010 | EP2155782A2 Mhc peptide complexes and uses thereof in infectious diseases |
| 02/24/2010 | EP2155775A2 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof |
| 02/24/2010 | EP2155771A1 Azido purine nucleosides for treatment of viral infections |
| 02/24/2010 | EP2155758A1 Tetrahydrofuro ý3 4-d¨dioxolane compounds for use in the treatment of viral infections and cancer |
| 02/24/2010 | EP2155745A1 6-(pyrrolopyridinyl)-pyrimidine-2-yl-amine derivatives |
| 02/24/2010 | EP2155716A2 Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials |
| 02/24/2010 | EP2155705A2 Compositions for regulating or modulating quorum sensing in bacteria, methods of using the compounds, and methods of regulating or modulating quorum sensing in bacteria |
| 02/24/2010 | EP2155692A1 Non-nucleoside reverse transcriptase inhibitors |
| 02/24/2010 | EP2155690A1 Indazolamide derivatives |
| 02/24/2010 | EP2155247A1 Prevention of staphylococcus biofilm formation |
| 02/24/2010 | EP2155230A1 Methods and compositions for use of cyclic analogues of histatin |
| 02/24/2010 | EP2155210A2 Use of nucleoside derivatives as anti-koi herpes virus in fish |
| 02/24/2010 | EP2155184A2 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies |
| 02/24/2010 | EP2154966A1 Benzimidazoles and pharmaceutical compositions thereof |
| 02/24/2010 | EP1954697B1 Peri condensed tricyclic compounds useful as antibacterial agents |
| 02/24/2010 | EP1200607B1 Tet repressor-based transcriptional regulatory proteins |
| 02/24/2010 | EP0837696B1 Improved delivery of diagnostic and therapeutic agents to a target site |
| 02/24/2010 | CN201410116Y Amoxicillin and sulbactam pivoxil dual-release capsule |
| 02/24/2010 | CN101654673A Rna interference mediating small rna molecules |
| 02/24/2010 | CN101654672A Rna interference mediating small rna molecules |
| 02/24/2010 | CN101654479A Mammalian receptor proteins, agents, and methods relating thereto |
| 02/24/2010 | CN101653603A Peptides and antibodies binding to anionic phospholipids and aminophospholipids and their use in treating disease |
| 02/24/2010 | CN100591760C Process for producing cytotoxic lymphocyte |
| 02/24/2010 | CN100591678C Piperidine derivatives useful as CCR5 antagonists |
| 02/24/2010 | CN100591329C Montelukast granule formulation |
| 02/24/2010 | CN100591320C Stable surfactant compositions for suspending components |
| 02/23/2010 | USRE41151 Comprising a modified NSAID, wherein the NSAID is covalently attached either directly or through a linker molecule to a sulfur-containing functional group containing an optionally substituted hydrocarbyl moiety; nonsteroidal anti-inflammatory drugs; side-effect reduction |
| 02/23/2010 | USRE41150 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors; compounds based on thieno(4,3,2-ef)(2)benzazepin-6-one |
| 02/23/2010 | USRE41149 Optically active pyridonecarboxylic acid derivatives |